Bedel Financial Consulting’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$224K Hold
1,000
0.03% 278
2025
Q4
$241K Sell
1,000
-1,100
-52% -$281K 0.03% 250
2025
Q3
$575K Hold
2,100
0.07% 145
2025
Q2
$542K Hold
2,100
0.07% 149
2025
Q1
$508K Hold
2,100
0.07% 147
2024
Q4
$509K Hold
2,100
0.07% 150
2024
Q3
$513K Hold
2,100
0.07% 138
2024
Q2
$402K Hold
2,100
0.06% 155
2024
Q1
$416K Hold
2,100
0.07% 158
2023
Q4
$361K Hold
2,100
0.07% 161
2023
Q3
$311K Hold
2,100
0.06% 168
2023
Q2
$459K Hold
2,100
0.1% 126
2023
Q1
$460K Hold
2,100
0.11% 122
2022
Q4
$437K Hold
2,100
0.11% 123
2022
Q3
$447K Hold
2,100
0.12% 120
2022
Q2
$440K Hold
2,100
0.13% 111
2022
Q1
$509K Hold
2,100
0.16% 91
2021
Q4
$547K Sell
2,100
-100
-5% -$25.9K 0.17% 83
2021
Q3
$580K Hold
2,200
0.2% 76
2021
Q2
$542K Hold
2,200
0.19% 83
2021
Q1
$427K Buy
+2,200
New +$441K 0.17% 101

Other funds holding RMD

Bedel Financial Consulting's RMD Position: Q1 2026 in Review

Bedel Financial Consulting held its ResMed (RMD) position steady in Q1 2026 at 1,000 shares worth $224K. The position accounts for 0.03% of the portfolio, ranked #278.

Bedel Financial Consulting first reported a position in RMD in Q1 2021 and has held it in 21 quarters since. The position peaked at $580K in Q3 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Bedel Financial Consulting held 1,000 shares of ResMed worth $224K as of Q1 2026.
  • Bedel Financial Consulting left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 0.03% of Bedel Financial Consulting's portfolio in Q1 2026, its #278 holding.
  • Bedel Financial Consulting first reported a position in ResMed in Q1 2021 and has held it in 21 quarters since.
  • Bedel Financial Consulting's ResMed position peaked at $580K in Q3 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Bedel Financial Consulting's 13F filing for Q1 2026, filed 4 May 2026.